Policy & Regulation
Nicox completes key data package for NCX 470 NDA submissions
16 December 2025 - Ophthalmology company Nicox SA (Euronext Growth Paris:ALCOX) announced on Tuesday that it has completed the generation and analysis of all clinical trial and long-term stability dat...
Immusoft's ISP-002 granted US FDA Orphan Drug Designation in MPS II
16 December 2025 - Clinical-stage biotechnology company Immusoft of CA, a subsidiary of Immusoft Corporation, announced on Monday that it has received Orphan Drug Designation from the US Food and Drug...
Orphan Therapeutics Accelerator signs MoU with Fondazione Telethon
16 December 2025 - Non-profit biotech company Orphan Therapeutics Accelerator (OTXL) announced on Monday that it has signed a Memorandum of Understanding (MoU) with Fondazione Telethon, an Italian non...
Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic
16 December 2025 - US biotechnology company Anixa Biosciences Inc (NASDAQ:ANIX) announced on Monday that it has completed the transfer of the Investigational New Drug application (IND) for its breast ...
Physiomics secures follow-on UK contract for Phase 2 study support
15 December 2025 - Physiomics plc (AIM: PYC), a mathematical modelling, data science and biostatistics company, announced on Monday that it has been awarded a follow-on contract with an existing UK cl...
Ascletis reports positive US Phase I data for oral IL-17 inhibitor ASC50
15 December 2025 - Biotechnology company Ascletis Pharma Inc (HKEX: 1672) on Monday reported positive topline results from a US randomised, double-blind, placebo-controlled Phase I single ascending do...